Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > 0.17$ versus 0.22$(+ warrant).

<< Previous

Bullboard Posts

Next >>

Comment by Rumpl3StiltSkinon Nov 14, 2023 12:48pm

232 Views

Post# 35734723

RE:RE:RE:0.17$ versus 0.22$(+ warrant).

I don't think those .28c warrants will cap anything. There aren't enough of them. IF TLT gets a JV or AA volume will go through the roof. :-) risky for sure though IF you think it will take longer than Aug.. I don't.

<< Previous

Bullboard Posts

Next >>

A potential breakthrough in spinal cord and optic nerve injury treatment